A. H. Mohieldein, M. Hasan, and M. I. El-Habiby, “High Sensitivity C-Reactive Protein as Atherogenic Marker Among Type 2 Diabetes”, ESJ, vol. 13, no. 33, p. 403, Nov. 2017.